Recent Advances in Low- and Intermediate-1–Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy Richard Stone, MD, Mikkael Sekeres, MD, MS, Guillermo Garcia-Manero, MD, Roger M. Lyons, MD, FACP Download PDF
